Contraceptives Flashcards
Gonadotrophin-releasing hormone (GnRH) released from ——
Hypothalamus
What hormoes are released during the Luteal phase
GnRH stimulates the Anterior pituitary which –> releases FSH –> Grafffian follicle growth -> Secretes Osterogen–> release of egg
What hormones are released during the Follicular phase ?
GnRH stimulates the Anterior Pituitary –> release LH –> ruptured follicle proliferates and becomes coprus leuteum –> secretes Progesterone
Function of Progesteron release during the luteal phase?
Induce fertilization
(by making cervivak mucus more viscous, less alkaline etc for the sperm)
Note: Progesteorne release stops if no fertilization happens -> mensturation
If Fertilization takes place —- keeps being released, which prevents further ovulation via the hypo. and Anterior pituitary effects
Progesterone
Oral Contraception methods used ?
1) Combo pill (Estrogen/Progesteron components)
2) Progestogens-only
1st generation Combo pill
Ethinylestradiol; mestranol
* not used anymore due to high concentrations of ER and Progesterone
2nd generation COCP
* COCP : combination oral contraceptive pill
1) Oestrogen component: lower dose
+
2) Progesterone: Testosterone derivatives
* Norethisterone, levonorgestrel, ethynodiol
*FIRST LINE*
Progesteron: Testosterone derivates used in Oral contraceptives , used in 2nd gen. COCP
Norethisterone,
levonorgestrel,
ethynodiol
3rd generation COCP
- Oestrogen component: lower dose
PLUS - Progesterone component—desogestrel or gestodene
CU of 3rd Generation COCP
- If 2nd gen. are not tolerated (break-through bleeding)
- given to women w/ acne, depression
CU of 2nd gen COCP
1st line oral contraception method
AE of 2nd generation COCP
- some androgenic activiy
AE of 3rd generation COCP
- Increased risk of Thromboembolism
Adv. of 3rd generation COCP over 2nd?
- more potent
- less androgenic action
- Less change in lipoprotein metabolism
BUT- has a greater risk of thromboembolism
how should the combo pill be taken?
Taken for 21 consecutive days, Followed by 7 pill-free days (mensturation)
MoA of Ostrogen in the Combination oral contraception pill
inhibits secretion of FSH via negative feedback on
anterior pituitary
–> Suppresses development of ovarian follicle
MoA of Progesteron in the Combiantion Oral Contraception pill
Inhibits secretion of LH –> Prevents ovulation -> Thickens cervical mucus: affects sperm passage
AE of COCP
- Weight gain
- Fluid retention or anabolic effects
- Nausea/vomiting
- Breast tenderness
- Flushing (ER is a vasodilator)
- Dizziness
- Depression (mostly 2nd gen)
- Irritability
- Skin changes
- Acne (2nd gen)
- Increase in pigmentation (2nd gen)
- Amenorrhea upon cessation
More sever AE of COCP
1) Cardiovascular risk
- Risk of VTE (3rd gen more than 2nd gen)
- Increased risk of MI/stroke (patients w/ risk factors are more suceptible i.e. >35 yrs, smoking, obesity)
2) Can cause increase in Bp
3) Cancer risk
- reduces risk of ovarian and endometrial cancer but,
- increases risk of Cervical and breast cancer
4) Irregular periods
**Safe in most women**
* risk is small
Contraindications of COCP
- Smokers >35 years old
- CV disease risk factors (CAD,VTE, stroke)
- Migraine
- ER-positive breast cancer
Note: more than one risk factor must be present for contraindication
Pharmacokinetic interactions of COCP
1) Metabolized by CYP450 enzymes
2) Inducers may lead to contraceptive failure
3) Abx may interfere with enterohepatic circulation of estrogen (and progesterone)
- women taking combo pill w/ Abx are adviced to use back up methods
Components of the Progestogen-only pill
Norethisterone, levonorgestrel, ethynodiol